Company Profile

General Biophysics LLC
Profile last edited on: 1/3/2024      CAGE: 7XEE7      UEI: MTDKKELM58W5

Business Identifier: Novel xenon therapies
Year Founded
2017
First Award
2021
Latest Award
2023
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1 Grant Street
Framingham, MA 01702
   (508) 780-0405
   info@generalphusics.com
   N/A
Location: Single
Congr. District: 05
County: Middlesex

Public Profile

A development stage biomedical technology company, General Biophysics is structured around exploirng xenon gas biological effect to develop medical technologies and translate them to therapies for the most challenging medical conditions. Pioneering groundbreaking solutions designed to harness the extraordinary capabilities of xenon to precisely control cellular responses, theexpertise of the assembled team organizes around gas measurement, administration, and mechanisms of biological actio, offering new dimensions in disease alleviation and biologic storage.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2023 2 NIH $2,131,543
Project Title: Xenon gas treatment to modulate microglia in neurodegenerative diseases

Key People / Management

  Ilya Ilin -- Chief Executive Officer

  Oleg Butovsky

Company News

There are no news available.